Skip to main content
. 2023 Apr 24;15(5):1328. doi: 10.3390/pharmaceutics15051328

Table 1.

Subtypes of PCLs according to WHO-EORTC classification 2018 and changes according to International Consensus Classification (ICC) of Mature Lymphoid Neoplasms 2021 [4,19].

Entity Disease Changes in ICC, 2021
CTCL MF
MF variants
  Folliculotropic MF
  Pagetoid reticulosis
  Granulomatous slack skin
SS
Adult T-cell leukemia/lymphoma
Primary cutaneous CD30+ LPDs
  C-ALCL
  LyP
Subcutaneous panniculitis-like T-cell lymphoma
Extranodal NK/T-cell lymphoma, nasal type
Chronic active EBV infection
Primary cutaneous peripheral T-cell lymphoma, rare subtypes
  Primary cutaneous γ/δ T-cell lymphoma
  CD8+ AECTCL (provisional)
  Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder (provisional)
  Primary cutaneous acral CD8+ T-cell lymphoma (provisional)
Primary cutaneous peripheral T-cell lymphoma, NOS
Primary cutaneous acral CD8+ T-cell LPD
CBCL PCMZL
PCFCL
PCDLBLC, LT
EBV+ mucocutaneous ulcer (provisional)
Intravascular large B-cell lymphoma
Primary cutaneous marginal zone LPD

MF: mycosis fungoides; SS: Sezary syndrome; LPD: lymphoproliferative disorder; C-ALCL: cutaneous anaplastic large cell lymphoma; LyP: lymphomatoid papulosis; CD8+ AECTCL: primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma; PCMZL: primary cutaneous marginal zone lymphoma; PCFDL: primary cutaneous follicle center lymphoma; PCDLBCL, LT: primary cutaneous diffuse large B-cell lymphoma, leg type.